Trial: 201601074

A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects with INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma

Phase

II (Cancer Control)

Principal Investigator

Van Tine, Brian

Disease Site

Bones and Joints

Learn more about this study at: clinicaltrials.gov